Long-term analysis of ABI auditory performance in patients with neurofibromatosis type 2-related schwannomatosis.
Humans
Neurofibromatosis 2
/ surgery
Male
Female
Adult
Retrospective Studies
Middle Aged
Neurofibromatoses
/ surgery
Speech Perception
/ physiology
Skin Neoplasms
/ surgery
Neurilemmoma
/ surgery
Auditory Brain Stem Implants
Follow-Up Studies
Young Adult
Auditory Brain Stem Implantation
/ methods
Treatment Outcome
Auditory brainstem implant
Hearing evaluation
Hearing loss
Tumor progression
Vestibular schwannoma
Journal
Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000
Informations de publication
Date de publication:
02 Oct 2024
02 Oct 2024
Historique:
received:
12
07
2024
accepted:
17
08
2024
medline:
2
10
2024
pubmed:
2
10
2024
entrez:
2
10
2024
Statut:
epublish
Résumé
This retrospective monocentric study aimed to evaluate long-term auditory brainstem implant (ABI) function in patients with neurofibromatosis type 2, and to investigate the prognostic factors for ABI use. Between 1997 and 2022, 27 patients with at least five years of follow-up underwent implantation with 32 ABIs. At 1- and 5-years post-implantation and at last follow-up, ABIs were classified as used or non-used and the size of the ipsilateral tumor was recorded. For patients who used their ABIs, we assessed speech perception (disyllabic words, MBAA sentences) in quiet conditions with the ABI only, by lip-reading (LR), and with a combination of the two (ABI + LR). Hearing improvement was calculated as One year post-implantation, 74% patients were ABI-users and 66% of the ABIs were used. Two of these patients were non-users at five years, and another two at last follow-up (14 ± 5.2 years); 54% of the patients were ABI-users at last follow-up. ABIs are indicated in case of bilateral deafness with a non-functional cochlear nerve. Half the patients with ABIs used their implants and auditory performance remained stable over time, except in cases of ipsilateral tumor growth.
Identifiants
pubmed: 39356313
doi: 10.1007/s00701-024-06243-3
pii: 10.1007/s00701-024-06243-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
390Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Références
Daoudi H, Lahlou G, Degos V, Sterkers O, Nguyen Y, Kalamarides M (2020) Improving facial nerve outcome and hearing preservation by different degrees of vestibular schwannoma resection guided by intraoperative facial nerve electromyography. Acta Neurochir (Wien) 162:1983–1993
doi: 10.1007/s00701-020-04397-4
pubmed: 32424567
Dornhoffer JR, Plitt AR, Lohse CM, Driscoll CLW, Neff BA, Saoji AA, Van Gompel JJ, Link MJ, Carlson ML (2024) Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis. Otol Neurotol 45:29–35
pubmed: 37875011
Edgerton BJ, House WF, Hitselberger W (1982) Hearing by cochlear nucleus stimulation in humans. Ann Otol Rhinol Laryngol Suppl 91:117–124
pubmed: 6805391
Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84:603–618
pubmed: 1484939
Gadenstaetter AJ, Auinger AB, Gerlitz M, Riss D, Dahm V, Yildiz E, Roessler K, Matula C, Arnoldner C (2023) Functional Outcome After Simultaneous Vestibular Schwannoma Resection and Cochlear Implantation With Intraoperative Cochlear Nerve Monitoring. Otolaryngol Head Neck Surg 168:1502
doi: 10.1002/ohn.233
pubmed: 36856581
Grayeli AB, Kalamarides M, Bouccara D, Ambert-Dahan E, Sterkers O (2008) Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients. Otol Neurotol 29:1140–1146
doi: 10.1097/MAO.0b013e31818b6238
pubmed: 18849886
Grenier B, Mosnier I, Ferrary E, Nguyen Y, Sterkers O, Kalamarides M, Lahlou G, Daoudi H (2024) Cochlear implantation in neurofibromatosis type 2-related schwannomatosis: long-term hearing outcomes. Otolaryngol Head Neck Surg 171:218
doi: 10.1002/ohn.702
pubmed: 38482961
Guex AA, Vachicouras N, Hight AE, Brown MC, Lee DJ, Lacour SP (2015) Conducting polymer electrodes for auditory brainstem implants. J Mater Chem B 3:5021–5027
doi: 10.1039/C5TB00099H
pubmed: 26207184
pmcid: 4507441
Halliday D, Emmanouil B, Pretorius P, MacKeith S, Painter S, Tomkins H, Evans DG, Parry A (2017) Genetic Severity Score predicts clinical phenotype in NF2. J Med Genet 54:657–664
doi: 10.1136/jmedgenet-2017-104519
pubmed: 28848060
Iannacone FP, Visconti F, Zanoletti E (2023) How Cochlear Implant Rehabilitation Impacts the Therapeutic Strategy for Vestibular Schwannoma. Audiol Res 13:116–129
doi: 10.3390/audiolres13010012
pubmed: 36825950
pmcid: 9952590
Jia H, El Sayed MME, Smail M, Mosnier I, Wu H, Sterkers O, Kalamarides M, Bernardeschi D (2018) Neurofibromatosis type 2: Hearing preservation and rehabilitation. Neurochirurgie 64:348–354
doi: 10.1016/j.neuchi.2018.09.003
pubmed: 30314805
Jia H, Torres R, Nguyen Y, De Seta D, Ferrary E, Wu H, Sterkers O, Bernardeschi D, Mosnier I (2018) Intraoperative Conebeam CT for Assessment of Intracochlear Positioning of Electrode Arrays in Adult Recipients of Cochlear Implants. Am J Neuroradiol 39:768–774
doi: 10.3174/ajnr.A5567
pubmed: 29472297
pmcid: 7410755
Kuchta J (2007) Twenty-five years of auditory brainstem implants: perspectives. Acta Neurochir Suppl 97:443–449
doi: 10.1007/978-3-211-33081-4_51
pubmed: 17691334
Lenarz T, Moshrefi M, Matthies C, Frohne C, Lesinski-Schiedat A, Illg A, Rost U, Battmer RD, Samii M (2001) Auditory brainstem implant: part I. Auditory performance and its evolution over time. Otol Neurotol 22:823–833
doi: 10.1097/00129492-200111000-00019
pubmed: 11698803
Maini S, Cohen MA, Hollow R, Briggs R (2009) Update on long-term results with auditory brainstem implants in NF2 patients. Cochlear Implants Int 10(Suppl 1):33–37
doi: 10.1002/cii.383
pubmed: 19230037
Nakatomi H, Miyawaki S, Kin T, Saito N (2016) Hearing Restoration with Auditory Brainstem Implant. Neurol Med Chir (Tokyo) 56:597–604
doi: 10.2176/nmc.ra.2016-0080
pubmed: 27464470
Nevison B, Laszig R, Sollmann W-P et al (2002) Results from a European clinical investigation of the Nucleus multichannel auditory brainstem implant. Ear Hear 23:170–183
doi: 10.1097/00003446-200206000-00002
pubmed: 12072610
Noonan KY, Rock J, Barnard Z, Lekovic GP, Brackmann DE, Wilkinson EP (2021) Bilateral Auditory Brainstem Implants in Patients With Neurofibromatosis 2. Otolaryngol Head Neck Surg 165:339–343
doi: 10.1177/0194599820977420
pubmed: 33317418
Peng KA, Lorenz MB, Otto SR, Brackmann DE, Wilkinson EP (2018) Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2. Laryngoscope 128:2163–2169
doi: 10.1002/lary.27181
pubmed: 29573425
Peyre M, Bernardeschi D, Sterkers O, Kalamarides M (2018) Natural history of vestibular schwannomas and hearing loss in NF2 patients. Neurochirurgie 64:342–347
doi: 10.1016/j.neuchi.2015.03.012
pubmed: 26183546
Peyre M, Goutagny S, Bah A, Bernardeschi D, Larroque B, Sterkers O, Kalamarides M (2013) Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results. Neurosurgery 72:907–913; discussion 914; quiz 914
Plotkin SR, Messiaen L, Legius E et al (2022) Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. Genet Med 24:1967–1977
doi: 10.1016/j.gim.2022.05.007
pubmed: 35674741
Ramsden RT, Freeman SRM, Lloyd SKW et al (2016) Auditory Brainstem Implantation in Neurofibromatosis Type 2: Experience From the Manchester Programme. Otol Neurotol 37:1267–1274
doi: 10.1097/MAO.0000000000001166
pubmed: 27525707
Shi J, Lu D, Gu R, Sun H, Yu L, Pan R, Zhang Y (2021) Reliability and toxicity of bevacizumab for neurofibromatosis type 2-related vestibular schwannomas: A systematic review and meta-analysis. Am J Otolaryngol 42:103148
doi: 10.1016/j.amjoto.2021.103148
pubmed: 34214711
Siegbahn M, Lundin K, Olsson G-B, Stillesjö F, Kinnefors A, Rask-Andersen H, Nyberg G (2014) Auditory brainstem implants (ABIs)–20 years of clinical experience in Uppsala, Sweden. Acta Otolaryngol 134:1052–1061
doi: 10.3109/00016489.2014.909051
pubmed: 24881643
Taslimi S, Zuccato JA, Mansouri A, Hachem LD, Badhiwala J, Kuchta J, Chen J, Pirouzmand F (2019) Novel Statistical Analyses to Assess Hearing Outcomes After ABI Implantation in NF2 Patients: Systematic Review and Individualized Patient Data Analysis. World Neurosurg 128:e669–e682
doi: 10.1016/j.wneu.2019.04.232
pubmed: 31059859
Vincent C (2012) Auditory brainstem implants: how do they work? Anat Rec (Hoboken) 295:1981–1986
doi: 10.1002/ar.22588
pubmed: 23044901
Wong K, Kozin ED, Kanumuri VV, Vachicouras N, Miller J, Lacour S, Brown MC, Lee DJ (2019) Auditory Brainstem Implants: Recent Progress and Future Perspectives. Front Neurosci 13:10
doi: 10.3389/fnins.2019.00010
pubmed: 30760974
pmcid: 6361749